day 3: genetics selcen guzey and tamara moore university of minnesota

69
Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Upload: jeffery-moody

Post on 15-Jan-2016

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Day 3: Genetics Selcen Guzey and Tamara Moore

University of Minnesota

Page 2: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Agenda

Teaching Genetics- Challenges, misconceptions, strategies, and questions

Content Assessment Genetic Variation Mutations Gene expression Lunch Integrating Genetic Engineering: Plasmids and

C. elegans lab

Page 3: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Teaching Genetics-Challenges, misconceptions, strategies, and questions

Use the post-it notes to create a “Parking Lot Chart” to be addressed throughout the day.

Challenge: integrating engineeringMisconceptions: structure of DNAStrategies: how to include published scientific

data into my genetics unitQuestion: What is a plasmid?

Page 4: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Genetic Variation

How much variation do you think exists among humans?

How much variation do you think exists between a human and a chimp?

How much variation do you think exists between a human and a Caenorhabditis elegans (C. elegans) (Nematode)?

Page 5: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Genomes Genomes vary in size, number of genes, and gene

density!

What genetic attributions allow humans to get by with no more genes than nematodes?

What makes humans and chimps so different?

Haploid genome sizebp: base (nucleotide) pairs

# of genes

E. coli 4.6 million bp 4,400

Caenorhabditis elegans (Nematode)

Chimpanzee

Human

100 million bp

3.3 billion bp

3 billion bp

20,100

19,700

<21,000

Page 6: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Human Genome

Page 7: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

DNA is the genetic material!

What piece of history is missing in this picture?

If you would like to recreate this picture who would be in this picture?

OR

Page 8: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Rosalind Franklin

Page 9: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

The structure of DNA

Page 10: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

The Structure of a Gene

EnhancerPromoter Exon IntronExon Intron

Poly-A signal sequence

Upstream Downstream

Exon

TATA and CAAT boxes, CG sequences

Transcription start site

Page 11: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota
Page 12: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Beta Hemoglobin (HbB)

Gene loci: 11p 15.5. 3 exons (coding regions)

scattered over 1600 base pairs

Yields a 626-bp mRNA transcript

Translated into a 147 amino acid polypeptide

Page 13: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Beta Hemoglobin Gene and Sickle Cell Anemia

SCA is an autosomal recessive disease caused by a point mutation in the hemoglobin beta gene (HBB).

The production of a structurally abnormal hemoglobin (Hb), called HbS.

It occurs in 1 in 500 individuals of African descent.http://www.hhmi.org/biointeractive/media/DNAi_sicklecell-lg.mov

Page 14: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Beta-Globin Gene In this activity, you will examine the DNA

sequence of the beta-globin gene from five people.

The codes represent the “sense” for the DNA sequence- Sense strand looks like mRNA.

1)Examine the gene sequence of Person A and B and find the difference in gene sequences of Person A and B (Look at position 6)

2)Examine the gene sequence of Person C, D, E, and F. Changes shown in bold!

Page 15: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

From DNA to mRNA3’- TTCAGTCGT - 5’ DNA template

strand5’- AAGTCAGCA- 3’ DNA sense strand Transcription

5’- AAGUCAGCA- 3’ mRNA codon

Translation

Lys Ser Ala Protein

Page 16: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

The codon table for mRNA

Page 17: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Questions for Discussion

Would a person who has a sequence like person A’s and a second sequence like person B’s have SC anemia?

Assume that a person has one allele with the sequence shown for person B and a second allele with the sequence shown for person F. Would the person have SC anemia?

Would person D and E have SC anemia? A person can have a mutation on beta-globin

gene and do not have SC. Propose a hypothesis to explain this.

Page 18: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

HBB-mutations

100 types of mutations affect HBB, and only one point mutation causes SC Anemia. (Person B)

Splice mutations and mutations that occur in the HBB gene promoter region tend to cause a reduction, rather than a complete absence of β-globin chains and so result in milder disease.

Nonsense mutations (Person D) and frameshift mutations (Person F) tend to not produce any β-globin chains leading to severe disease.

Silence mutations are rare (Person C and E).

Page 19: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

More on Mutations

Gene mutation- Point mutations/single base substitutions

a)Substitutions CCC CCAb)Frameshift mutations:

insertions and deletions 5’ CCC CCA GGG 3’ 5’CCC CCA AGA GGG 3’

Chromosomal Mutations

a)Deletionb)Duplicationc) Inversiond)Translocation

Point mutations can be also categorized as: nonsense mutations, missense mutations, and silent mutations

Page 20: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Testing for Sickle Cell AnemiaMst II recognizes the sequence CCTNAGG and cut the DNA where N is. DNA from normal homozygous individuals (AA), heterozygous carriers of the trait (AS), and homozygous sickle cell patients (SS) produces different sizes of restriction fragments.When the fragments are separated by gel electrophoresis the patterns result on the gel can be used to identify people with sickle cell anemia.

1. Which family members have the sickle cell genotype (SS), carrier genotype (AS), or the normal genotype (AA)?

2. Draw a pedigree showing inheritance of sickle cell anemia in the family.

3. Make a Punnett Square and explain the probabilities of various genotypes and phenotypes for offspring of 2 carrier parents.

Page 21: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota
Page 22: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Mst II recognizes the sequence CCTNAGG

Page 23: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Gene Expression: Switching genes on and off

Gene expression in humans is controlled by a variety of mechanisms:

Transcriptional control that prevents mRNA from being synthesized: Heterochromatin vs. Euchromatin, acetylation/deacetylation of DNA, DNA methylation, transcription factors (activators and inhibators)

Posttranscriptional control: Alternative mRNA splicing Transitional control: Initiation factorsPosttransitional control: Protein activation

Cancer results from genes that do not turn off properly. Cancer cells have lost their ability to regulate mitosis, resulting in uncontrolled cell division!

Page 24: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Transcriptional

Post transcriptional

Transitional

Post transitional

Page 25: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Analyzing gene expressionCase Study - What’s wrong with Raymond?

Presentation:

Raymond, a 43-year-old man, was admitted to the hospital with a rapidly growing, painless mass in his armpit. He reports that he has been experiencing fever, weight loss, and night sweats during the past four months.

Page 26: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Case Study - What’s wrong with Raymond?

Tests: Enlarged lymph nodes were removed and the histology of the cells was examined, revealing abnormal B cells. A bone marrow biopsy was done, along with additional blood tests, X-rays, and CT scans.

Diagnosis:Raymond has lymphoma.

Page 27: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

What is lymphoma? http://video.about.com/lymphoma/Non-Hodgki

n-s-Lymphoma.htm

Page 28: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Case Study - What’s wrong with Raymond?

Tests: Enlarged lymph nodes were removed and the histology of the cells was examined, revealing abnormal B cells. A bone marrow biopsy was done, along with additional blood tests, X-rays, and CT scans.

Diagnosis:Raymond has diffuse large B-cell lymphoma (DLBCL).

Page 29: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Diffuse large B-cell lymphoma

What is it? What is the prognosis?

Lymphoma = tumor of white blood cells

time (yrs)

# s

urv

ivors

type A

type B

1 2 3 4 5 6 7 8 9

Page 30: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Does Raymond have Type A or Type B?

http://emedicine.medscape.com/article/202677-media

Page 31: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Challenge Since there is no observable difference in

Type A and Type B tumors, how could you determine which type of DLBCL your patient has?

• Type A (GCB): good prognosis with chemotherapy

• Type B (ABC): poor prognosis with chemotherapy

http://emedicine.medscape.com/article/202677-media

Page 32: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Proteins! How could you find the protein differences

between cells of Type A and Type B DLBCL?

Page 33: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Stephen Friend et al. 2002 Sci. Am. 286:44-49http://bcs.whfreeman.com/lodish6e Chapter 5 animationhttp://www.bio.davidson.edu/courses/genomics/chip.chip.html

Differences in protein…Surrogate: differences in mRNA

Page 34: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

DNA microarray http://www.genome.gov/10000533

Page 35: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

DNA microarray analysis

Elevated mRNAin lymphoma

Decreased mRNAin lymphoma

Similarlevels of mRNA

Analyze genes expressed in tumors

http://llmpp.nih.gov/ http://lymphochip.nih.gov/signaturedb/http://llmpp.nih.gov/lymphoma/explore_figure1.html

Page 36: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Gene 1

Gene 2

Gene 3

Gene 4

Gene 5

Gene 6

Page 37: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

How do we organize microarray data?

Compare your gene expression profile to others within your group, to identify those whose cancer cells share the most similarity to yours.

Organize all of the strips into a single panel, and stick them to a piece of paper using double-sided tape.

Can you classify the patients in your group into categories based on gene expression? If so, how many categories?

Page 38: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota
Page 39: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota
Page 40: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota
Page 41: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota
Page 42: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota
Page 43: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota
Page 44: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota
Page 45: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota
Page 46: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota
Page 47: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

1 3 5 2 4 6

tumor sample

123456

Page 48: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

1 3 5 2 4 6

tumor sample

123456

Page 49: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

1 3 5 2 4 6

tumor sample

123456

Tumor Sample

Page 50: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Lymphoma Case Study

Prognosis: On the basis of gene expression patterns what is Raymond’s prognosis?

DLBCL subgroup 5-year survival rate

A 60-70%

B 25-35%

time (yrs)

# s

urv

ivors type A

type B

1 2 3 4 5 6 7 8 9

Raymond

Subgroup BSubgroup A

Page 51: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

If you were a lymphoma patient, would you want to know your subgroup?

A. Yes, definitely. I want to know immediately.

B. Maybe, but I want to have discussions with my family first.

C. No, but I want my physician to do the testing to determine subgroup and chemotherapeutic treatment.

D. No.

E. I’d rather not choose.

time (yrs)

# s

urv

ivors type A

type B

1 2 3 4 5 6 7 8 9

Page 52: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Genetic Engineering

What is biotechnology? What is genetic engineering? What can genetic engineering do? What are some examples of genetically

engineered products?

Page 53: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Gene cloning and uses of cloned genes

Page 54: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

DNA Insertion into a Plasmid

Individually, read the memo and the article

Observe the DNA sequence of plant A, plasmid DNA, and restriction enzymes

Develop your procedure for this process (which is a model).

Page 55: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Additional Notes: You will make a physical paper model of the

insertion of the pesticide resistant gene into the plant DNA to help the technicians “see” the process you are describing to them.

Restriction site (This is the location where the insertion of the gene will work.)

The technicians already know the process for adding the Ampicillin resistant gene, so the plasmid DNA provided for our model already includes the Ampicillin resistant gene. However, in the lab, the insertion of the Ampicillin resistant gene and the pesticide resistant gene will happen at the same time. Therefore, you don’t need to worry about the Ampicillin resistant gene insertion.

Page 56: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Caenorhabditis elegans: The worm

Why study C. elegans?

It is eukaryotic just like us. It has DNA as genetic materials. It produces RNA and

protein as well. It is a multicellular organism. It develops from an embryo (sperm + egg) to adult

using developmental processes It grows, reproduces, gets old and dies. It has a digestive system for eating, a nerve system

with a "brain" for "learning" and muscles to help it move.

Its genome size is small (~ 10 Megabase) with about 40% homology to human (3.2 Gigabase).

Page 57: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Lab experiments with C. elegans

Its size is small. The adult worm is only 1 mm. This makes it possible to house large numbers in a laboratory setting.

The total number of somatic cells in an adult worm is about 959 cells comparing to human's trillions of cells.

Its life cycle/span is short (about 3 days/weeks respectively). This shortens the amount of time needed for each experiment and increases the speed of scientific progress.

It is transparent. This characteristic makes it an excellent tool for studying biology questions like cell division and cell lineage (a cell's family tree).

It is non-parasitic free-living that feeds on bacteria (e.g. E. coli). This makes it safe for use in laboratory settings.

Page 58: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Life Cycle

Page 59: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Lab Activity

Each plate contains a different C. elegans strand. Observe the worms and then write down your observations. Note any differences in morphology or behavior.

Why do you think some worms move different than the others?

How do you silence the gene that you think has mutation in it?

As a group, write down a hypothesis and then design an experimental study to test your hypothesis.

Page 60: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Dmpy11: Short and fat

L1-L3 worm, and adult L4 in the center, and several adult hermaphrodites

Bli-1:blisters on the cuticle of the worms

Rol 6: Rollers

Page 61: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

RNAi lab with C. elegans

Step 1: Grow E. coli overnight cultures

Step 2: Seed NGM-LITE and NGM-LITE/amp+IPTG plates with E. coli

Step 3: Transfer C. elegans to OP50-Seeded NGM-LITE plates

Step 4:Induce RNAi by feeding

Page 62: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

More information about C. elegans http://www.wormbook.org

Where to find C. elegans? C. elegans center at the U of Mnhttp://www.cbs.umn.edu/CGC/ Carolina bio supplywww.carolina.com

Page 63: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota

Contact informationSelcen [email protected]

Tamara [email protected]

Page 64: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota
Page 65: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota
Page 66: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota
Page 67: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota
Page 68: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota
Page 69: Day 3: Genetics Selcen Guzey and Tamara Moore University of Minnesota